Newsmakers: Gilead, Amedisys, Compugen, ICAD, Cara Therapeutics

U.S. stocks dipped and bonds slid after the Federal Reserve offered a brighter assessment of the U.S. job market, a shift that investors reckoned could bring forward the timing of interest-rate increases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.